改变世界:5年心脏外科跨社会联盟 (CSIA)
R M Bolman1, P Zilla2, F Beyersdorf3
1Division of Cardio-Thoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, USA.
Asian cardiovascular & thoracic annals
|June 14, 2024
概括
心脏外科协会联盟 (CSIA) 在莫桑比克和卢旺达建立了试点项目,以建立可持续的心脏外科能力. 这些举措成功地增加了病例数量,政府承诺和基础设施,证明了全球心脏手术发展的可行模式.
科学领域:
- 全球健康 全球健康
- 心血管外科心血管外科
- 发展中国家经济体的发展.
背景情况:
- 发展中国家心脏外科手术的巨大未满足需求.
- 在全球范围内,获得基本心血管护理的机会不平等.
- 需要可持续的,局部心脏手术能力.
研究的目的:
- 为了解决心脏外科护理的差距.
- 在低收入国家倡导和建立可持续的心脏手术能力.
- 实施和评估心脏外科开发的试点项目.
主要方法:
- 形成心脏外科跨社会联盟 (CSIA).
- 全球需求评估确定风湿性心脏病作为主要病理.
- 在莫桑比克和卢旺达选择和指导试点地点.
- 与合作机构签订培训和指导协议.
主要成果:
- 在莫桑比克和卢旺达成功实施试点项目.
- 增加心脏手术病例数和政府在试点地点的承诺.
- 显著的基础设施升级和行业/捐助者参与.
- 在当地心脏外科手术项目中展示了可持续性和能力建设.
结论:
- CSIA模型有效地建立了发展中国家的可持续心脏手术能力.
- 莫桑比克和卢旺达的试点项目显示出显著的积极成果.
- 扩大CSIA的"批准印章"可以进一步推动全球心脏外科手术的发展.
更多相关视频
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
3.6K
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
3.4K
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
